Summit Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Summit Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2017 to Q3 2024.
  • Summit Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $7.98M, a 24.6% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $7.98M +$1.57M +24.6% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $8.72M +$1.72M +24.6% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $9.37M +$5.45M +139% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $5.86M +$1.68M +40.3% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $6.4M +$2.17M +51.4% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $7M +$4.98M +247% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $3.93M +$1.5M +61.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $4.18M +$1.39M +49.6% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $4.23M +$2.35M +125% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $2.02M -$195K -8.82% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.43M +$945K +63.6% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $2.79M +$2.24M +404% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $1.88M +$1.26M +200% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $2.21M +$1.53M +226% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.49M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $554K -$467K -45.7% Dec 31, 2020 10-K/A 2022-12-21
Q3 2020 $628K Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $679K Jun 30, 2020 8-K 2020-09-29
Q4 2019 $1.02M -$351K -25.6% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $1.37M -$605K -30.6% Jan 31, 2019 8-K 2020-09-29
Q4 2017 $1.98M Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.